史丹利(002588) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥2,628,527,213.63, a decrease of 13.86% compared to ¥3,051,379,055.39 in the same period last year[4]. - Net profit attributable to shareholders increased by 11.27% to ¥238,491,511.67 from ¥214,341,836.19 year-on-year[4]. - Basic and diluted earnings per share rose by 10.53% to ¥0.21 from ¥0.19 in the same period last year[4]. - Net profit for Q1 2024 was CNY 222,245,429.03, slightly up from CNY 218,261,797.33 in Q1 2023, representing a growth of 1.8%[17]. - Earnings per share for Q1 2024 increased to CNY 0.21, compared to CNY 0.19 in the previous year[18]. Cash Flow - The net cash flow from operating activities was negative at -¥10,592,095.89, a decline of 129.08% compared to ¥36,427,588.73 in the previous year[8]. - Operating cash flow for the current period was -10,592,095.89 CNY, a decrease from 36,427,588.73 CNY in the previous period[19]. - Total cash outflow from operating activities was 2,471,034,437.27 CNY, compared to 2,399,143,938.35 CNY in the previous period[19]. - Cash inflow from sales of goods and services was 2,384,618,088.82 CNY, slightly up from 2,374,407,586.73 CNY[19]. - Cash paid to employees increased to 185,767,359.47 CNY from 142,248,716.64 CNY year-over-year[19]. - Cash received from other operating activities was 75,824,252.56 CNY, up from 56,707,877.12 CNY in the previous period[19]. Assets and Liabilities - Total assets decreased by 3.77% to ¥12,300,946,160.69 from ¥12,782,482,045.55 at the end of the previous year[4]. - The total current assets as of March 31, 2024, amounted to ¥5,127,192,831.61, a decrease from ¥6,304,956,434.44 at the beginning of the period, reflecting a decline of approximately 18.7%[13]. - Total liabilities decreased to CNY 4,969,320,308.83 from CNY 5,669,829,056.91, reflecting a reduction of 12.3%[15]. - Non-current liabilities increased to CNY 857,086,954.44, up from CNY 537,123,374.46, indicating a rise of 59.6%[15]. - The total amount of other current assets decreased from ¥1,269,350,391.88 to ¥634,724,266.17, a decline of approximately 50%[13]. Investments - Investment income increased by 80.83% to ¥51,438,605.84, attributed to higher returns from joint ventures[8]. - The company reported investment income from joint ventures of CNY 51,050,660.85, compared to CNY 29,271,306.69 in the previous year, marking a growth of 74.5%[17]. - The company's long-term equity investments rose to ¥1,073,958,920.19 from ¥1,022,908,259.34, indicating an increase of about 5%[13]. Shareholder Information - The company had a total of 43,142 common shareholders at the end of the reporting period[10]. - The top shareholder, Gao Wenban, holds 23.12% of the shares, with 118,830,000 shares pledged[10]. Other Financial Metrics - The company reported a significant increase in other income, which rose by 328.08% to ¥33,308,672.49, primarily due to increased government subsidies[8]. - Total operating costs decreased to CNY 2,462,115,911.48, down 13.3% from CNY 2,840,970,861.20 year-over-year[16]. - Research and development expenses were CNY 91,298,250.55, down from CNY 104,740,801.94, a decrease of 12.9%[16]. Strategic Insights - The company has not disclosed any new product developments or market expansion strategies in the current report[12]. - There were no mentions of mergers or acquisitions in the latest earnings call, suggesting a focus on internal growth strategies[12].